| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.01. | AFT Pharmaceuticals - Another R&D asset in the bag | 288 | Edison Investment Research | AFT Pharmaceuticals has announced the addition of another candidate, HY-091, to its R&D pipeline, for the management of vulvar lichen sclerosus (VLS), a skin condition with no curative treatments available.... ► Artikel lesen | |
| 22.01. | Accsys Technologies - Updating estimates for guidance and capital raise | 397 | Edison Investment Research | In September 2023, Accsys warned of weaker market conditions in the building materials and construction markets and in November, it stated not to expect trading conditions to improve materially until... ► Artikel lesen | |
| 22.01. | OSE Immunotherapeutics - Active year ahead for proprietary programmes | 347 | Edison Investment Research | OSE has refreshed its outlook for 2024, including the commencement of the confirmatory Phase III trial for lead asset Tedopi (an off-the-shelf, neoepitope-based cancer vaccine) in second-line non-small... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 367 |
| EVOTEC | 329 |
| TUI | 245 |
| NVIDIA | 201 |
| DEUTSCHE BANK | 196 |
| BAYER | 179 |
| PLUG POWER | 159 |
| NEL | 151 |
| RHEINMETALL | 150 |
| SIEMENS ENERGY | 133 |
| COMMERZBANK | 122 |
| BARRICK GOLD | 120 |
| TESLA | 116 |
| BASF | 114 |
| VOLKSWAGEN | 109 |
| DEUTSCHE LUFTHANSA | 104 |
| RWE | 103 |
| BYD | 101 |
| ALLIANZ | 94 |
| DEUTSCHE TELEKOM | 93 |
| MERCEDES-BENZ | 92 |
| RENK GROUP | 89 |
| E.ON | 83 |
| ALIBABA | 82 |
| HEIDELBERGER DRUCK | 82 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
